PANCREATIC ADENOSQUAMOUS CARCINOMA
Clinical trials for PANCREATIC ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial tests best timing for chemo in pancreatic cancer
Disease control OngoingThis phase III trial tests whether giving chemotherapy before and after surgery (perioperative) works better than giving it only after surgery (adjuvant) for people with pancreatic cancer that can be removed. The study involves 358 participants and uses a combination of four chem…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for BRCA pancreatic cancer? trial tests adding cisplatin to standard chemo
Disease control OngoingThis phase II/III trial compares a three-drug chemotherapy combination (nab-paclitaxel, gemcitabine, plus cisplatin) against the standard two-drug combo (nab-paclitaxel plus gemcitabine) in people with metastatic pancreatic cancer that has BRCA1, BRCA2, or PALB2 gene mutations. T…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC